Similar articles

• [Outcome assessment in treatment of edaravone in childhood ischemic stroke].

  Osaka H, Okazaki S. Osaka H, et al. No To Hattatsu. 2008 Sep;40(5):403-5. No To Hattatsu. 2008. PMID: 18807890 Japanese. No abstract available.
• Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion.

  Toyoda K, Fujii K, Kamouchi M, Nakane H, Arihiro S, Okada Y, Ibayashi S, Iida M. Toyoda K, et al. J Neurol Sci. 2004 Jun 15;221(1-2):11-7. doi: 10.1016/j.jns.2004.03.002. J Neurol Sci. 2004. PMID: 15178207 Clinical Trial.
• Inhibition of brain damage by edaravone, a free radical scavenger, can be monitored by plasma biomarkers that detect oxidative and astrocyte damage in patients with acute cerebral infarction.

  Uno M, Kitazato KT, Suzue A, Matsuzaki K, Harada M, Itabe H, Nagahiro S. Uno M, et al. Free Radic Biol Med. 2005 Oct 15;39(8):1109-16. doi: 10.1016/j.freeradbiomed.2005.06.001. Free Radic Biol Med. 2005. PMID: 16198237 Clinical Trial.
• Edaravone for the treatment of acute cerebral infarction: role of endothelium-derived nitric oxide and oxidative stress.

  Higashi Y. Higashi Y. Expert Opin Pharmacother. 2009 Feb;10(2):323-31. doi: 10.1517/14656560802636888. Expert Opin Pharmacother. 2009. PMID: 19236202 Review.
• Edaravone Mitsubishi-Tokyo.

  Tabrizchi R. Tabrizchi R. Curr Opin Investig Drugs. 2000 Nov;1(3):347-54. Curr Opin Investig Drugs. 2000. PMID: 11249718 Review.